Synergy Pharmaceuticals – Seeks Authorization for $155mn in DIP Loan Financing

December 12, 2018 – Synergy Pharmaceuticals requested Court authority to enter into a $115 million debtor-in-possession (“DIP”) loan arrangement [Docket No. 15].    The motion states, “In the weeks leading up to the Petition Date, the Debtors and their advisors engaged in extensive, hard-fought negotiations with their prepetition lenders regarding potential proposals for debtor-in-possession financing…